As of 2024-12-12, the EV/EBITDA ratio of Cross Country Healthcare Inc (CCRN) is 16.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CCRN's latest enterprise value is 529.86 mil USD. CCRN's TTM EBITDA according to its financial statements is 33.08 mil USD. Dividing these 2 quantities gives us the above CCRN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 16.4x | 15.8x |
| Forward P/E multiples | 8.3x - 14.7x | 11.6x |
| Fair Price | 17.56 - 38.53 | 24.26 |
| Upside | -2.7% - 113.6% | 34.5% |
| Date | EV/EBITDA |
| 2024-12-10 | 16.05 |
| 2024-12-09 | 16.04 |
| 2024-12-06 | 16.06 |
| 2024-12-05 | 16.05 |
| 2024-12-04 | 16.14 |
| 2024-12-03 | 9.17 |
| 2024-12-02 | 9.53 |
| 2024-11-29 | 8.77 |
| 2024-11-27 | 8.81 |
| 2024-11-26 | 8.67 |
| 2024-11-25 | 8.88 |
| 2024-11-22 | 8.35 |
| 2024-11-21 | 8.39 |
| 2024-11-20 | 8.22 |
| 2024-11-19 | 8.38 |
| 2024-11-18 | 8.35 |
| 2024-11-15 | 7.83 |
| 2024-11-14 | 8.03 |
| 2024-11-13 | 8.12 |
| 2024-11-12 | 9.04 |
| 2024-11-11 | 8.76 |
| 2024-11-08 | 8.37 |
| 2024-11-07 | 10.27 |
| 2024-11-06 | 10.16 |
| 2024-11-05 | 9.46 |
| 2024-11-04 | 9.23 |
| 2024-11-01 | 9.34 |
| 2024-10-31 | 9.42 |
| 2024-10-30 | 9.71 |
| 2024-10-29 | 9.85 |
| 2024-10-28 | 9.82 |
| 2024-10-25 | 9.58 |
| 2024-10-24 | 9.82 |
| 2024-10-23 | 9.85 |
| 2024-10-22 | 10.01 |
| 2024-10-21 | 10.03 |
| 2024-10-18 | 10.87 |
| 2024-10-17 | 11.25 |
| 2024-10-16 | 10.40 |
| 2024-10-15 | 10.32 |
| 2024-10-14 | 10.28 |
| 2024-10-11 | 10.33 |
| 2024-10-10 | 10.19 |
| 2024-10-09 | 10.25 |
| 2024-10-08 | 10.39 |
| 2024-10-07 | 10.48 |
| 2024-10-04 | 10.24 |
| 2024-10-03 | 10.78 |
| 2024-10-02 | 10.89 |
| 2024-10-01 | 11.10 |